scholarly article | Q13442814 |
P2093 | author name string | Jennifer O Black | |
P2860 | cites work | Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients | Q24530548 |
Xeroderma pigmentosum | Q24594728 | ||
The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta | Q28115711 | ||
Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy | Q28272049 | ||
Neurological symptoms and natural course of xeroderma pigmentosum | Q33345341 | ||
Defective Repair Replication of DNA in Xeroderma Pigmentosum | Q34054000 | ||
Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases | Q34183159 | ||
Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. | Q35164298 | ||
Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease | Q35470522 | ||
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. | Q35605167 | ||
Shining a light on xeroderma pigmentosum | Q35757364 | ||
Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. | Q36444039 | ||
Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage | Q36986273 | ||
Cerebro-oculo-facio-skeletal syndrome. | Q37778048 | ||
Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. | Q38177867 | ||
DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease | Q38563227 | ||
Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect | Q41939016 | ||
Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair | Q42440575 | ||
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. | Q53068627 | ||
Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light | Q57971918 | ||
DNA Repair Dysfunction and Neurodegeneration: Lessons From Rare Pediatric Disorders | Q64049273 | ||
Genetic Heterogeneity of Xeroderma Pigmentosum demonstrated by Somatic Cell Hybridization | Q69000572 | ||
Defect in DNA Synthesis in Skin of Patients with Xeroderma Pigmentosum Demonstrated in vivo | Q71509246 | ||
Absence of excision of ultraviolet-induced cyclobutane dimers in xeroderma pigmentosum | Q71535172 | ||
Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphocytes | Q71789722 | ||
P433 | issue | 2 | |
P304 | page(s) | 139-144 | |
P577 | publication date | 2016-03-14 | |
P1433 | published in | Head and Neck Pathology | Q15816982 |
P1476 | title | Xeroderma Pigmentosum. | |
P478 | volume | 10 |
Q58712798 | Biomarkers of Cellular Senescence and Skin Aging |
Q55054189 | Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders? |
Q92890851 | DNA repair fidelity in stem cell maintenance, health, and disease |
Q89511629 | Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis |
Q92999447 | Neurogenic bladder associated with xeroderma pigmentosum type A: A case report and literature review |
Q100737103 | Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients |
Q93066251 | Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series |
Q64042356 | Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms |
Search more.